ARCHIVES

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

75% Of Fed Research Funds Pay Direct Costs, Study Says.

July 28, 2000

In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC

May 19, 2000

NCI Supercomputer Operations To Start In April

November 15, 1985

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

February 15, 1991

Clinical Trials Approved Last Month By NCI’s CTEP

May 31, 2002

Drug Development Gets Extra $500,000

November 18, 1977